It warrants further explore whether TIM-3 receives an inhibitory signal from an unidentified molecule other than galectin-9 on tumor cells where blockade of this interaction by anti-TIM-3 mAb elicits an immunostimulatory effect. The gene discussed is HAVCR2; the disease is neoplasm.